Q2 FY26 revenue rises 35%, profit jumps sharply; interim dividend approved

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹943.00

prior close

₹943.00

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-0.2%-1.7% vs market

Pharmaceuticals peers, median of 154sector-0.3%-1.7% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Midcap 150 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.9

10m

-3.9

15m

-4.1

30m

-3.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0-0.2-1.7-0.3-1.7

Next day

-0.3+0.6-0.9-0.5+0.1

+1.9+0.6+1.3-0.4+2.3

+1.8+1.1+0.7+0.1+1.7

+2.8+1.0+1.8+0.4+2.4

+1.3+0.5+0.8+0.1+1.2

+4.3+0.9+3.4-0.4+4.7

15d

+8.7+2.5+6.2-1.3+10.0

+4.2+0.6+3.6-3.6+7.8

+15.2+1.4+13.8-4.5+19.6

+5.9-3.7+9.7-12.3+18.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unaudited consolidated results for the quarter ended September 30, 2025 show revenue up 35.1% at Rs 1,653.47 crore versus Rs 1,223.70 crore. Profit attributable to equity holders rose to Rs 194.97 crore from Rs 19.84 crore. Six-month revenue rose 33.3% to Rs 3,223.04 crore and profit to Rs 357.99 crore from Rs 32.35 crore. Operating cash flow was Rs 1,093.13 crore. The board approved a Rs 0.80 per share interim dividend.

Likely market impact

Strong profit growth, operating cash flow and the Rs 0.80 per share dividend are shareholder positives; low cash and borrowing remain watch points.